Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-cancer Cell Immunotherapy”

337 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 337 results

Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)UnknownNCT05267392
What this trial is testing

Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy

Who this might be right for
Non-small Cell Lung Cancer
Instituto Portugues de Oncologia, Francisco Gentil, Porto 30
Testing effectiveness (Phase 2)Study completedNCT02336815
What this trial is testing

Selinexor Treatment of Refractory Myeloma

Who this might be right for
Multiple Myeloma
Karyopharm Therapeutics Inc 202
Testing effectiveness (Phase 2)Looking for participantsNCT06045910
What this trial is testing

A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, Large B-Cell, DiffuseLymphoma, Mantle-Cell+3 more
Cancer Research UK 84
Testing effectiveness (Phase 2)Ended earlyNCT00924287
What this trial is testing

Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic Cancer

Who this might be right for
Metastatic Cancer
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Looking for participantsNCT07381075
What this trial is testing

A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
West China Hospital 90
Early research (Phase 1)Looking for participantsNCT07572136
What this trial is testing

Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Who this might be right for
B-AllAcute Lymphoblastic Leukemia
National Cancer Institute (NCI) 57
Testing effectiveness (Phase 2)Study completedNCT03304639
What this trial is testing

Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma

Who this might be right for
Advanced Merkel Cell CarcinomaClinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8+5 more
National Cancer Institute (NCI) 9
Early research (Phase 1)Study completedNCT03602612
What this trial is testing

T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma

Who this might be right for
Myeloma-MultipleMyeloma, Plasma-Cell
National Cancer Institute (NCI) 35
Very early researchActive Not RecruitingNCT04656535
What this trial is testing

AB154 Combined With AB122 for Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Yale University 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07818304
What this trial is testing

SRT Combined With Envafolimab and Endostar in the First-line Treatment of Advanced NSCLC

Who this might be right for
Non Small Cell Lung CancerLung Neoplasms
The First People's Hospital of Lianyungang 61
Not applicableUnknownNCT03671265
What this trial is testing

Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 20
Not applicableUnknownNCT02838433
What this trial is testing

Study of Anti-telomerase T CD4 Immunity in Melanoma

Who this might be right for
Melanoma
Centre Hospitalier Universitaire de Besancon 200
Testing effectiveness (Phase 2)Study completedNCT00847106
What this trial is testing

Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients

Who this might be right for
Melanoma
Radboud University Medical Center 15
Early research (Phase 1)Study completedNCT01137006
What this trial is testing

An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant Melanoma

Who this might be right for
Malignant Melanoma
Eli Lilly and Company 27
Testing effectiveness (Phase 2)UnknownNCT03191773
What this trial is testing

Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies

Who this might be right for
Acute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaLymphoma
Second Affiliated Hospital of Guangzhou Medical University 100
Not applicableUnknownNCT05510466
What this trial is testing

Triple BRAFinh/MEKinh /antiPD1 Combined Therapy in Patients With BRAF Mutated Melanoma With Central Nervous System Metastasis

Who this might be right for
Metastatic Melanoma
University Hospital, Montpellier 18
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Early research (Phase 1)Active Not RecruitingNCT05797233
What this trial is testing

Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaB-Cell Chronic Lymphocytic LeukemiaLymphoma, B-Cell
National Cancer Institute (NCI) 58
Early research (Phase 1)Study completedNCT03049449
What this trial is testing

T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas

Who this might be right for
Lymphoma, Large-Cell, AnaplasticEnteropathy-Associated T-Cell LymphomaLymphoma, Large B-Cell, Diffuse+2 more
National Cancer Institute (NCI) 26
Next Page